J Nowak1, C Seidel2, F Berg3, T Pietsch4, C Friedrich5, K von Hoff5, S Rutkowski5, M Warmuth-Metz6. 1. From the Reference Center for Neuroradiology (J.N., C.S., F.B., M.W.-M.), University Hospital of Würzburg, Würzburg, Germany Nowak_j1@ukw.de. 2. From the Reference Center for Neuroradiology (J.N., C.S., F.B., M.W.-M.), University Hospital of Würzburg, Würzburg, Germany Department of Radiology, Pathology Research (C.S.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. 3. From the Reference Center for Neuroradiology (J.N., C.S., F.B., M.W.-M.), University Hospital of Würzburg, Würzburg, Germany Department of Radiology and Neuroradiology (F.B.), University of Witten/Herdecke, Cologne-Merheim Medical Center, Cologne, Germany. 4. Department of Neuropathology (T.P.), Brain Tumor Reference Center, Bonn, Germany. 5. Department of Pediatric Hematology and Oncology (C.F., K.v.H., S.R.), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 6. From the Reference Center for Neuroradiology (J.N., C.S., F.B., M.W.-M.), University Hospital of Würzburg, Würzburg, Germany.
Abstract
BACKGROUND AND PURPOSE: Ependymoblastoma is a malignant embryonal tumor that develops in early childhood and has a dismal prognosis. Categorized by the World Health Organization as a subgroup of CNS-primitive neuroectodermal tumor, ependymoblastoma is histologically defined by "ependymoblastic rosettes." Because it is so rare, little is known about specific MR imaging characteristics of ependymoblastoma. We systematically analyzed and discussed MR imaging features of ependymoblastoma in a series of 22 consecutive patients. MATERIALS AND METHODS: Ependymoblastoma cases were obtained from the database of the German multicenter HIT trials between 2002 and 2013. All cases within this study were centrally reviewed for histopathology, MR imaging findings, and multimodal therapy. For systematic analysis of initial MR imaging scans at diagnosis, we applied standardized criteria for reference image evaluation of pediatric brain tumors. RESULTS: Ependymoblastomas are large tumors with well-defined tumor margins, iso- to hyperintense signal on T2WI, and diffusion restriction. Contrast enhancement is variable, with a tendency to mild or moderate enhancement. Subarachnoid spread is common in ependymoblastoma but can be absent initially. There was a male preponderance (1.75:1 ratio) for ependymoblastoma in our cohort. Mean age at diagnosis was 2.1 years. CONCLUSIONS: With this study, we add the largest case collection to the limited published database of MR imaging findings in ependymoblastoma, together with epidemiologic data. However, future studies are needed to systematically compare MR imaging findings of ependymoblastoma with other CNS-primitive neuroectodermal tumors and ependymoma, to delineate imaging criteria that might help distinguish these pediatric brain tumor entities.
BACKGROUND AND PURPOSE:Ependymoblastoma is a malignant embryonal tumor that develops in early childhood and has a dismal prognosis. Categorized by the World Health Organization as a subgroup of CNS-primitive neuroectodermal tumor, ependymoblastoma is histologically defined by "ependymoblastic rosettes." Because it is so rare, little is known about specific MR imaging characteristics of ependymoblastoma. We systematically analyzed and discussed MR imaging features of ependymoblastoma in a series of 22 consecutive patients. MATERIALS AND METHODS:Ependymoblastoma cases were obtained from the database of the German multicenter HIT trials between 2002 and 2013. All cases within this study were centrally reviewed for histopathology, MR imaging findings, and multimodal therapy. For systematic analysis of initial MR imaging scans at diagnosis, we applied standardized criteria for reference image evaluation of pediatric brain tumors. RESULTS:Ependymoblastomas are large tumors with well-defined tumor margins, iso- to hyperintense signal on T2WI, and diffusion restriction. Contrast enhancement is variable, with a tendency to mild or moderate enhancement. Subarachnoid spread is common in ependymoblastoma but can be absent initially. There was a male preponderance (1.75:1 ratio) for ependymoblastoma in our cohort. Mean age at diagnosis was 2.1 years. CONCLUSIONS: With this study, we add the largest case collection to the limited published database of MR imaging findings in ependymoblastoma, together with epidemiologic data. However, future studies are needed to systematically compare MR imaging findings of ependymoblastoma with other CNS-primitive neuroectodermal tumors and ependymoma, to delineate imaging criteria that might help distinguish these pediatric brain tumor entities.
Authors: K M Gauvain; R C McKinstry; P Mukherjee; A Perry; J J Neil; B A Kaufman; R J Hayashi Journal: AJR Am J Roentgenol Date: 2001-08 Impact factor: 3.959
Authors: Chiaho Hua; Thomas E Merchant; Amar Gajjar; Alberto Broniscer; Yong Zhang; Yimei Li; George R Glenn; Larry E Kun; Robert J Ogg Journal: Int J Radiat Oncol Biol Phys Date: 2011-06-12 Impact factor: 7.038
Authors: Andrey Korshunov; Marc Remke; Marco Gessi; Marina Ryzhova; Thomas Hielscher; Hendrik Witt; Vivienne Tobias; Anna Maria Buccoliero; Iacopo Sardi; Marina Paola Gardiman; Jose Bonnin; Bernd Scheithauer; Andreas E Kulozik; Olaf Witt; Sverre Mork; Andreas von Deimling; Otmar D Wiestler; Felice Giangaspero; Marc Rosenblum; Torsten Pietsch; Peter Lichter; Stefan M Pfister Journal: Acta Neuropathol Date: 2010-04-21 Impact factor: 17.088
Authors: Carsten Friedrich; André O von Bueren; Katja von Hoff; Nicolas U Gerber; Holger Ottensmeier; Frank Deinlein; Martin Benesch; Robert Kwiecien; Torsten Pietsch; Monika Warmuth-Metz; Andreas Faldum; Joachim Kuehl; Rolf D Kortmann; Stefan Rutkowski Journal: Neuro Oncol Date: 2012-12-07 Impact factor: 12.300
Authors: Katja von Hoff; Bernward Hinkes; Nicolas U Gerber; Frank Deinlein; Uwe Mittler; Christian Urban; Martin Benesch; Monika Warmuth-Metz; Niels Soerensen; Isabella Zwiener; Heiko Goette; Paul G Schlegel; Torsten Pietsch; Rolf D Kortmann; Joachim Kuehl; Stefan Rutkowski Journal: Eur J Cancer Date: 2009-02-26 Impact factor: 9.162
Authors: V Dangouloff-Ros; A Tauziède-Espariat; C-J Roux; R Levy; D Grévent; F Brunelle; A Gareton; S Puget; K Beccaria; T Blauwblomme; J Grill; C Dufour; P Varlet; N Boddaert Journal: AJNR Am J Neuroradiol Date: 2019-03-07 Impact factor: 3.825
Authors: M Benesch; T Perwein; G Apfaltrer; T Langer; A Neumann; I B Brecht; M U Schuhmann; H Cario; M C Frühwald; K Vollert; M van Buiren; M Y Deng; A Seitz; C Haberler; M Mynarek; C Kramm; F Sahm; P A Robe; J W Dankbaar; K V Hoff; M Warmuth-Metz; B Bison Journal: AJNR Am J Neuroradiol Date: 2022-09-22 Impact factor: 4.966
Authors: Julia E Neumann; Annika K Wefers; Sander Lambo; Edoardo Bianchi; Marie Bockstaller; Mario M Dorostkar; Valerie Meister; Pia Schindler; Andrey Korshunov; Katja von Hoff; Johannes Nowak; Monika Warmuth-Metz; Marlon R Schneider; Ingrid Renner-Müller; Daniel J Merk; Mehdi Shakarami; Tanvi Sharma; Lukas Chavez; Rainer Glass; Jennifer A Chan; M Mark Taketo; Philipp Neumann; Marcel Kool; Ulrich Schüller Journal: Nat Med Date: 2017-09-11 Impact factor: 53.440